Found 129 matching trials
Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma PHASE2 Background:
The disease follicular lymphoma (FL) develops when the body ma...
Show More Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Rituximab for GVHD PHASE2 This is a prospective, open-label pilot study in which 4 doses of Rituximab...
Show More Location
Methodist Hospital
Learn More & Join Trial
ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular Lymphoma PHASE2 Primary Objective: To compare the complete response rate (CR rate) after in...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab PHASE3 SUMMARY: This is a multi-center open label study to evaluate the safety and...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
Ma-Spore ALL 2020 Study PHASE2 The primary objective of this trial is to improve the overall survival rate...
Show More Location
Subang Jaya Medical Centre
Learn More & Join Trial
Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) PHASE2 This study is a prospective, open-label, multicenter study in previously un...
Show More Location
The Affiliated Hospital of Xuzhou Medical University
Learn More & Join Trial
Ibrutinib Plus Rituximab for cGVHD Following Allo-SCT PHASE1 Allogeneic stem cell transplant is used to treat a variety of blood cancers...
Show More Location
Dartmouth-Hitchcock Medical Center
Learn More & Join Trial
Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection PHASE2 In small initial studies, combined kidney and bone marrow transplants from ...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis PHASE1 Background:
GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma PHASE1 The goal of this clinical research study is to see if high-dose chemotherap...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial